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Possible Influence of Growth Hormone on Sebum Excretion in Man
Sir. The effects of pituitary hormones on the sebum excretion rate (SER) have been studied instates of hypopituitarism [1] and in patients sufferingfrom acromegaly [2] , Data available suggest the presence of a pituitary sebotrophic factor in man. Animal studies have shown that growth hormone (GH) is one possible such sebotrophic factor, as GH can restore the response of the sebaceous glands to testosterone in hypophysectomised rats [3] . Since these studies were made ‚ it has however become clear that the effects of GH are not due to a direct action of the hormone but rather to somatomedins or growth factors induced by GH. Little is known about the relationship of SER to human GH (hGH) or insulin-like growth factor 1 (IGF-1) in normal healthy volunteers. To study a possible relationship, hGH, IGF-1 and SER were studied in 8 healthy male volunteers, aged 24-38 years. The SER was measured using the Sebumeter SM420R (Schwartzhaupt, Cologne, FRG) which correlates well with other methods of measuring the SER [4, 5] . It was measured in two symmetrical areas near the glabella, and the average value was used. The mean SER was 86.1 arbitrary units/h, with a range of 22.5-171 arbitrary units/h. Similarly the mean serum hGH was < 0.7 mIU/1, with a range of < 0.4-2.2 mIU/1. The mean IFG-1 was 127.9 ng/ml, with a range of 104-151 ng/ml. There was no significant correlation between the SER and hGH nor between the SER and IFG-1 (correlation: -0.1 and -0.2; R2 = 1.5-2 and 0.1). Chemical analysis was kindly provided by Kabi Vitrum, Sweden. Clofazimine for Residual Nodulocystic Acne Lesions Patients affected by nodulocystic acne treated with isotretinoin, at the correct dose and during an adequate time, may present some residual suppurative fibrocystic nodules, principally on the back of the neck. There are few therapeutic possibilities for such lesions. Local and systemic antibiotics do not help, radiotherapy gives only a transitory response and surgery, which necessitates a wide incision, leaves a very visible scar. Recently 3 patients who presented this kind of residual suppurative fibrocystic nodule on the back of the neck have been treated with clofazimine. The results were spectacular, between 1 and 3 months after completed treatment. The patients were all male, aged 27, 22 and 24 years, and had a nodulocystic acne which had been treated by isotretinoin (0.5-0.75 mg/kg/day) for 5 months. They presented recurrence of acne 1 year later needing a second isotretinoin cycle at a dose of 1 mg/ kg/day for 3 months. On completing the second treatment the acne lesions were cured, but a residual suppurative focus persisted on the back of the neck. The residual nodule of the third patient was treated by radiotherapy (Siemens Dermopan II; total dose 600 cGy, 50 kV, 25 mA, FSD 15 cm, filter 1.0 Al) with only slight improvement. The patients (weight 70 ± 5 kg) were given oral clofazimine 100 mg/ daily, two for 3 months, one for 7 months. The suppurative focus cleared. No side effects or skin pigmentation were seen. Some months after stopping clofazimine a discrete recurrence has been observed in the first and third patient, easily controlled by topical erythromycin
